Restrictive allograft dysfunction rather than bronchiolitis obliterans syndrome had a major impact on the overall survival after living-donor lobar lung transplantation
Surgery Today · 2024
DOI: 10.1007/s00595-023-02729-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Surgery Today, 2024. Verfasst von Kei Matsubara und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Thoracic Surgery and Breast and Endocrinological Surgery, Dentistry and Pharmaceutical Sciences, Okayama University Graduate Sc…. Hauptthemen laut MEDLINE: Bronchiolitis Obliterans Syndrome, Bronchiolitis Obliterans, Lung Transplantation, Primary Graft Dysfunction. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 18 Literaturangaben.
Abstract (Originalsprache)
PURPOSE: Chronic lung allograft dysfunction (CLAD) is a known long-term fatal disorder after lung transplantation. In this study, we evaluated the CLAD classification of the International Society for Heart and Lung Transplantation (ISHLT) for living-donor lobar lung transplantation (LDLLT). METHODS: We conducted a single-center retrospective review of data from 73 patients who underwent bilateral LDLLT between 1998 and 2019. Factors related to opacity on computed tomography (CT) and restriction on pulmonary function tests (PFTs) were also analyzed. RESULTS: Overall, 26 (36%) patients were diagnosed with CLAD, including restrictive allograft syndrome (RAS), n = 10 (38.5%); bronchiolitis obliterans syndrome (BOS), n = 8 (30.8%); mixed, n = 1 (3.8%); undefined, n = 2 (7.7%); and unclassified, n = 5 (19.2%). The 5-year survival rate after the CLAD onset was 60.7%. The survival of patients with BOS was significantly better than that of patients with RAS (p = 0.012). In particular, patients with restriction on PFT had a significantly worse survival than those without restriction (p = 0.001). CONCLUSIONS: CLAD after bilateral LDLLT does not have a major impact on the recipient survival, especially in patients with BOS. Restriction on PFT may predict a particularly poor prognosis in patients with CLAD after bilateral LDLLT.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of General Thoracic Surgery and Breast and Endocrinological Surgery, Dentistry and Pharmaceutical Sciences, Okayama University Graduate School of Medicine, 2-5-1 Shikata-cho, Kita-ku, Okayama, Okayama, 700-85…
- Department of Cardiovascular and Thoracic Surgery, Ehime University Hospital, 454 Shitsukawa, Toon, Ehime, 791-0295, Japan. otani.shinji.iz@ehime-u.ac.jp.
- Latner Thoracic Surgery Research Laboratories, Toronto General Hospital Research Institute, University Health Network, Toronto, ON, Canada.
Zitieren
APA
Matsubara, K., Otani, S., Yamamoto, H., Hashimoto, K., Tanaka, S., Shien, K., Suzawa, K., Miyoshi, K., Yamamoto, H., Okazaki, M., Sugimoto, S., & Toyooka, S. (2024). Restrictive allograft dysfunction rather than bronchiolitis obliterans syndrome had a major impact on the overall survival after living-donor lobar lung transplantation. Surgery Today. https://doi.org/10.1007/s00595-023-02729-2
Vancouver
Matsubara K, Otani S, Yamamoto H, Hashimoto K, Tanaka S, Shien K, et al. Restrictive allograft dysfunction rather than bronchiolitis obliterans syndrome had a major impact on the overall survival after living-donor lobar lung transplantation. Surgery Today. 2024. doi:10.1007/s00595-023-02729-2
BibTeX
@article{Matsubara2024,
author = {Matsubara, Kei and Otani, Shinji and Yamamoto, Haruchika and Hashimoto, Kohei and Tanaka, Shin and Shien, Kazuhiko and Suzawa, Ken and Miyoshi, Kentaroh and Yamamoto, Hiromasa and Okazaki, Mikio and Sugimoto, Seiichiro and Toyooka, Shinichi},
title = {Restrictive allograft dysfunction rather than bronchiolitis obliterans syndrome had a major impact on the overall survival after living-donor lobar lung transplantation},
journal = {Surgery Today},
year = {2024},
doi = {10.1007/s00595-023-02729-2}
}
EUVIMED